Exxonmobil Investment Management Inc. TX decreased its position in shares of Henry Schein Inc. (NASDAQ:HSIC) by 1.7% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,885 shares of the company’s stock after selling 358 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Henry Schein were worth $3,404,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in shares of Henry Schein by 2.2% in the second quarter. Vanguard Group Inc. now owns 7,493,463 shares of the company’s stock worth $1,324,844,000 after buying an additional 161,065 shares during the last quarter. BlackRock Fund Advisors raised its stake in shares of Henry Schein by 2.4% in the second quarter. BlackRock Fund Advisors now owns 2,369,132 shares of the company’s stock worth $418,863,000 after buying an additional 55,384 shares in the last quarter. Janus Capital Management LLC raised its stake in shares of Henry Schein by 16.5% in the second quarter. Janus Capital Management LLC now owns 2,027,848 shares of the company’s stock worth $358,522,000 after buying an additional 286,929 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in shares of Henry Schein by 55.7% in the second quarter. UBS Asset Management Americas Inc. now owns 802,401 shares of the company’s stock worth $141,865,000 after buying an additional 286,976 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Henry Schein by 17.3% in the second quarter. Franklin Resources Inc. now owns 559,193 shares of the company’s stock worth $98,865,000 after buying an additional 82,404 shares in the last quarter. Hedge funds and other institutional investors own 91.35% of the company’s stock.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein Inc. (NASDAQ:HSIC) traded up 1.24% during trading on Tuesday, hitting $153.24. 981,014 shares of the company’s stock traded hands. The company has a market cap of $12.33 billion, a PE ratio of 25.45 and a beta of 1.09. The company’s 50 day moving average price is $154.22 and its 200 day moving average price is $166.36. Henry Schein Inc. has a 52-week low of $142.64 and a 52-week high of $183.00.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Wednesday, November 2nd. The company reported $1.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.03. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The business earned $2.87 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter last year, the firm posted $1.55 EPS. Henry Schein’s revenue was up 6.7% compared to the same quarter last year. Analysts expect that Henry Schein Inc. will post $6.58 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This news story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was stolen and republished in violation of United States and international copyright and trademark law. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/29/exxonmobil-investment-management-inc-tx-has-3404000-position-in-henry-schein-inc-hsic.html.

A number of analysts have recently commented on HSIC shares. Zacks Investment Research lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. JPMorgan Chase & Co. reissued a “hold” rating and issued a $163.00 price objective on shares of Henry Schein in a research report on Thursday, November 3rd. Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective on the stock in a research report on Tuesday, October 11th. Robert W. Baird lowered shares of Henry Schein from an “outperform” rating to a “neutral” rating and cut their price objective for the stock from $176.00 to $164.00 in a research report on Friday, October 14th. Finally, Bank of America Corp. initiated coverage on shares of Henry Schein in a research report on Monday, September 12th. They issued a “buy” rating and a $185.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Henry Schein currently has a consensus rating of “Hold” and a consensus price target of $172.83.

In related news, EVP Mark E. Mlotek sold 2,417 shares of Henry Schein stock in a transaction on Thursday, November 3rd. The shares were sold at an average price of $155.19, for a total value of $375,094.23. Following the completion of the sale, the executive vice president now owns 40,456 shares of the company’s stock, valued at approximately $6,278,366.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.27% of the stock is currently owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.